How is your wife doing on the trial btw?
While I would recommend that anyone with MS making an educated consideration of available clinical trials, I have to admit that there is more to it than there seems.
What comes with entrance into a clinical trial is the undying need to try to determine if you are on the "real" treatment, and what the course of your MS might have been otherwise.
She was diagnosed in Feb? March? of 2006 and got her first Tovaxin injection in May of 2007. Although my wife experienced no outward signs, the baseline MRI for the Tovaxin trial showed a new enhancing lesion.
What she experienced was that her EDSS went from 3.0 at one appointment and 3.5 at the time of her first injection, down to a 1.0 at the time of her second injection. Did the Tovaxin do it? Was it time for that lesion to "resolve" on it's own? Did the Tovaxin bring a quick end to what might have been a humdinger of a lesion? Is she even on Tovaxin or placebo? I have no way of knowing with certainty.
Has MRI shown any new lesions since that time? What has her EDSS done since that time? To be honest, to avoid giving myself and others the wrong impression I've been staying out of the room so that I don't know any of that information and can't report it.
As far as we can tell, my wife is doing wonderfully. No new symptoms, no noticeable advancement since she was diagnosed, but that isn't necessarily proof positive because people have had an "event", gone ten years with nothing and then got hammered.
Personally, I have very strong belief in Tovaxin and the double blind/placebo clinical trial is something which has to be endured until she gets in the open label phase next May.
Please, those in other countries should have a little more patience with our Commander in Chief. This is a trying time and he's just a little mixed up right now
Bob